- Home
- BBIO vs DINO Comparison
BBIO vs DINO Comparison
Compare BBIO & DINO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- DINO
- Stock Information
- Founded
- BBIO 2015
- DINO 1947
- Country
- BBIO United States
- DINO United States
- Employees
- BBIO N/A
- DINO N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- DINO Oil & Gas Production
- Sector
- BBIO Health Care
- DINO Energy
- Exchange
- BBIO Nasdaq
- DINO Nasdaq
- Market Cap
- BBIO 6.7B
- DINO 6.2B
- IPO Year
- BBIO 2019
- DINO N/A
- Fundamental
- Price
- BBIO $34.25
- DINO $36.12
- Analyst Decision
- BBIO Strong Buy
- DINO Buy
- Analyst Count
- BBIO 12
- DINO 10
- Target Price
- BBIO $57.09
- DINO $44.89
- AVG Volume (30 Days)
- BBIO 2.9M
- DINO 2.7M
- Earning Date
- BBIO 04-29-2025
- DINO 05-01-2025
- Dividend Yield
- BBIO N/A
- DINO 5.54%
- EPS Growth
- BBIO N/A
- DINO N/A
- EPS
- BBIO N/A
- DINO N/A
- Revenue
- BBIO $127,415,000.00
- DINO $27,923,000,000.00
- Revenue This Year
- BBIO $89.10
- DINO N/A
- Revenue Next Year
- BBIO $57.07
- DINO $1.64
- P/E Ratio
- BBIO N/A
- DINO N/A
- Revenue Growth
- BBIO N/A
- DINO N/A
- 52 Week Low
- BBIO $21.62
- DINO $24.66
- 52 Week High
- BBIO $39.54
- DINO $55.24
- Technical
- Relative Strength Index (RSI)
- BBIO 50.58
- DINO 60.89
- Support Level
- BBIO $31.77
- DINO $35.41
- Resistance Level
- BBIO $33.93
- DINO $36.81
- Average True Range (ATR)
- BBIO 1.28
- DINO 1.03
- MACD
- BBIO -0.09
- DINO -0.07
- Stochastic Oscillator
- BBIO 57.14
- DINO 57.82
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About DINO HF Sinclair Corporation
HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.